CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15 | -59.5% | 17,536 | -48.7% | 0.00% | – |
Q2 2023 | $37 | -73.8% | 34,165 | -75.1% | 0.00% | -100.0% |
Q1 2023 | $141 | -7.2% | 137,221 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $152 | -99.6% | 137,221 | +331.5% | 0.00% | – |
Q3 2022 | $35,000 | -31.4% | 31,799 | -10.0% | 0.00% | – |
Q2 2022 | $51,000 | – | 35,333 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |